与阿尔茨海默氏病相关的保护变体Plcg2-P522R以性别二态的方式调节外周巨细胞功能
Hannah A Staley1,2,3, Janna E Jernigan1,2,3, MacKenzie L Bolen1,2,3
1Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, USA.
Journal of neuroinflammation
|November 2, 2024
概括
脂酶C玛2 (PLCG2) 基因中的保护性突变显示出对免疫细胞的性别依赖性影响. 这一发现对于了解阿尔茨海默氏症 (AD) 和开发向疗法至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 全基因组关联研究确定了脂酶C玛2 (PLCG2) 基因对抗阿尔茨海默病 (AD) 相关认知衰退的保护性突变 (P522R).
- PLCG2主要表达在免疫细胞中,是潜在的AD治疗的目标.
- 在微质中,P522R等位基是超形态的,增强了粉样蛋白-β (Aβ) fagocytosis 和炎症性细胞因子释放.
研究的目的:
- 为了研究P522R PLCG2突变对外围组织居民巨细胞的影响.
- 为了确定性别是否会改变巨细胞中P522R突变的功能影响.
主要方法:
- 来自具有和没有P522R PLCG2突变的个体的外围巨细胞的比较分析.
- 评估巨细胞的功能,包括细胞分裂,溶酶蛋白酶活性,细胞因子分泌和基因表达.
- 基于性别的结果分层.
主要成果:
- 带有P522R突变的外周巨细胞表现出取决于性别的功能变化.
- 在雌性巨细胞中,P522R增加了溶酶蛋白酶活性,细胞因子分泌和与亡相关的基因表达.
- 在雄性巨细胞中,P522R降低了细胞分裂和溶酶蛋白酶活性,与适度的细胞因子增加和诱导免疫抑制基因表达.
结论:
- 根据细胞类型和性别,P522R PLCG2突变对巨细胞产生不同的功能影响.
- 性别是一个关键的生物变量,在评估遗传变异和开发针对AD的免疫向疗法时要考虑.
更多相关视频
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
1.3K
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
770
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...